Published in Ann Surg Oncol on August 01, 2001
Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg (2005) 1.65
Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol (2011) 1.18
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg (2007) 1.02
Sphincter-preserving operations following preoperative chemoradiation: an alternative to abdominoperineal resection for lower rectal cancer? World J Surg (2008) 0.93
Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur Radiol (2005) 0.89
Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur Radiol (2015) 0.87
Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer. Surg Today (2013) 0.81
Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study. Br J Cancer (2006) 0.81
Distal clearance margin of 1 cm or less: a safe distance in lower rectum cancer surgery. Int J Colorectal Dis (2008) 0.76
Oncologic outcomes in rectal cancer with close distal resection margins: a retrospective analysis. Ann Surg Treat Res (2015) 0.75
Potential pathological understaging of pT3 rectal cancer with less than 26 lymph nodes recovered: a prospective study based on a resampling of 50 rectal specimens. Virchows Arch (2006) 0.75
Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet (1998) 4.46
Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J (1999) 3.51
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. Ann Oncol (2008) 2.75
Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer. Cancer J Sci Am (2006) 2.42
Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial. Lancet (2001) 2.40
Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. JPEN J Parenter Enteral Nutr (2000) 2.36
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer (1995) 2.28
Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg (2000) 2.27
Distant metastases in ovarian carcinoma. Int J Gynecol Cancer (2003) 2.20
I get by with a little help from my family and friends: adolescents' support for diabetes care. J Pediatr Psychol (1995) 2.03
Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg (1999) 2.00
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med (2000) 1.93
Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol (2000) 1.92
Randomized, controlled trial of behavior therapy for families of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol (2000) 1.79
Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int (2007) 1.64
Molecular basis for CD40 signaling mediated by TRAF3. Proc Natl Acad Sci U S A (2000) 1.64
Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus (1999) 1.58
In-utero platelet transfusion for alloimmune thrombocytopenia. Lancet (1988) 1.55
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors. Breast Cancer Res Treat (1999) 1.54
Adequacy of margins of resection in gastrectomy for cancer. Ann Surg (1982) 1.52
Prevention and treatment of central venous catheter sepsis by exchange via a guidewire. A prospective controlled trial. Ann Surg (1983) 1.48
Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: the experience of the National Cancer Institute of Milano. Ann Surg Oncol (2000) 1.45
Comparing reconstruction with Roux-en-Y to a pouch following total gastrectomy. J Am Coll Surg (1996) 1.44
TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem (1999) 1.35
Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg (1997) 1.32
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials. Ann Oncol (2007) 1.29
Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res (1997) 1.29
Celiac disease and selective immunoglobulin A deficiency. J Pediatr (1997) 1.28
A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet (1986) 1.27
Behavior therapy for families of adolescents with diabetes: maintenance of treatment effects. Diabetes Care (2001) 1.23
Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol (2013) 1.20
Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology (2012) 1.16
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. J Clin Oncol (2001) 1.15
Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem. Br J Surg (1986) 1.15
[A case of prolonged apnea in Huntington's chorea]. Acta Anaesthesiol (1968) 1.13
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. Cancer Lett (2008) 1.11
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. J Clin Oncol (1996) 1.09
Cervical cytopathology. An evaluation of its accuracy based on cytohistologic comparison. Cancer (1993) 1.09
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing. J Immunol (1998) 1.08
Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet (1987) 1.08
Consequences of fetomaternal haemorrhage after intrauterine transfusion. BMJ (1988) 1.08
Monilethrix treated with minoxidil. Int J Immunopathol Pharmacol (2011) 1.06
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases. Ann Hematol (2002) 1.06
The biological functions of polyamine oxidation products by amine oxidases: perspectives of clinical applications. Amino Acids (2004) 1.05
Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano. Eur J Surg Oncol (2008) 1.05
Consensus conference on laparoscopic appendectomy: development of guidelines. Colorectal Dis (2011) 1.04
Distal intramural spread in adenocarcinoma of the lower third of the rectum treated with total rectal resection and coloanal anastomosis. Dis Colon Rectum (1997) 1.03
Blood culture as a guide for the diagnosis of central venous catheter sepsis. JPEN J Parenter Enteral Nutr (1984) 1.02
Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. J Control Release (2007) 1.02
Giant cell arteritis of the posterior cerebral circulation presenting with ataxia and ophthalmoplegia. Arch Ophthalmol (1984) 1.01
Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol (1986) 1.01
Comparison of nutritional status after total or subtotal gastrectomy. Nutrition (1992) 1.00
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy. Cancer Res (1999) 0.99
Directive and nondirective social support in diabetes management. Int J Behav Med (1997) 0.98
Results of extended surgery for cancer of the rectum and sigmoid. Br J Surg (1982) 0.98
Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study. Virchows Arch (1999) 0.97
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer. Ann Oncol (2007) 0.97
The Drosophila tumor necrosis factor receptor-associated factor-1 (DTRAF1) interacts with Pelle and regulates NFkappaB activity. J Biol Chem (2000) 0.97
Preoperative risk stratification in patients undergoing elective infrarenal aortic aneurysm surgery: evaluation of five risk scoring methods. Eur J Vasc Endovasc Surg (2004) 0.97
Lipid peroxidation products and antioxidant enzymes in red blood cells during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol (1993) 0.96
Indications and outcome for intensive care unit admission during puerperium. Arch Gynecol Obstet (2001) 0.96
Manual dissection of adenocarcinoma of the lower third of the rectum specimens for detection of lymph node metastases smaller than 5 mm. Cancer (1996) 0.96
Comparison between the minimum margin defined on preoperative imaging and the final surgical margin after hepatectomy for cancer: how to manage it? Ann Surg Oncol (2007) 0.94
PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. Drug Dev Ind Pharm (2000) 0.93
Choice of cesarean section and perception of legal pressure. J Perinat Med (2000) 0.92
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. Fam Cancer (2012) 0.92
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2. Int J Cancer (1988) 0.92
Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer. Int J Cancer (1999) 0.92
Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer. Br J Cancer (2007) 0.91
Chitosan-alginate microparticles as a protein carrier. Drug Dev Ind Pharm (2001) 0.91
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer. Ann Oncol (2007) 0.91
Transvaginal sonography and hysteroscopy in postmenopausal uterine bleeding. Maturitas (1999) 0.91
Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum (2014) 0.90
The differential response to chemotherapy of ovarian metastases from colorectal carcinoma. Eur J Surg Oncol (2008) 0.90
Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy. Oncology (1995) 0.90
Time-dependent relevance of steroid receptors in breast cancer. J Clin Oncol (2000) 0.89
Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2. Cancer Immunol Immunother (1993) 0.89
Social validity of support group and behavior therapy interventions for families of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol (1997) 0.89
[Chemotherapy in the treatment of ovarian carcinosarcoma]. Minerva Ginecol (1999) 0.89
The pathogenesis of endometrial polyps: a systematic semi-quantitative review. Eur J Gynaecol Oncol (2013) 0.89
Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol (2005) 0.89
Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women. Br J Cancer (2000) 0.89
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan. Cancer (1994) 0.88
Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs). Neurology (2009) 0.88
Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. Int J Pharm (1999) 0.88
How long is a 6 cm margin of resection in the stomach? Eur J Surg Oncol (1992) 0.88
Value of the Glasgow Aneurysm Score in predicting the immediate and long-term outcome after elective open repair of infrarenal abdominal aortic aneurysm. Br J Surg (2003) 0.88